January 14, 2009 – A published report of a meta-analysis by Thad Wilkins, M.D., et al. in the January/February issue of Annals of Family Medicine on colonoscopy screening for colorectal cancer performed by primary care physicians raises several important issues regarding the quality of the exam, the safety of patients and the effectiveness of detecting colorectal cancer and pre-cancerous changes in the colon, said the American College of Gastroenterology, but noted the study might be misleading.

"The clinical evidence supports the College's position that the training and experience of the endoscopist are critical to a quality colonoscopy and cancer detection," said Eamonn M.M. Quigley, M.D., FACG, president of the American College of Gastroenterology. "The College advises patients to seek a well-trained endoscopist who performs many of these tests and has a record of performing a complete examination of the colon. A patient undergoing a colonoscopy must be assured that their examination will truly be capable of detecting any and all abnormalities that could indicate disease or a predisposition to cancer. Otherwise, colon cancer will not be prevented."

"Any physician who performs colonoscopy needs to meet a high standard, and must be capable of interpreting all possible abnormalities seen, dealing with any therapeutic interventions that may arise, and managing the patient's safety," added Dr. Quigley.

The College believes that the findings of the Wilkins study are potentially misleading.

"This study is a meta-analysis of reports from selected centers reporting detection rates of adenomas and cancers in screening colonoscopies by primary care physicians. These data from selected centers are less generalizable than data obtained from population-based studies on detection rates of neoplasia," said Douglas K. Rex, M.D., FACG, a representative of the ACG to the U.S. Multi-Society Task Force on Colorectal Cancer.

Available evidence directly comparing primary care physicians to gastroenterologists for the most important endpoint in colonoscopy, i.e. detection of cancer, indicates that gastroenterologist performance on average is clearly superior to primary care physicians'. According to Dr. Rex, all three population-based studies that have determined miss rates for colorectal cancer during colonoscopy by specialty have found that primary care physicians are more likely than gastroenterologists to miss colorectal cancer during colonoscopy (Rex et al Gastroenterology; 1997: 112:17-23; Bressler et al Gastroenterology 2007; 132:96-102; Singh et al Gastroenterology 2007; 132:A-149).

Dr. Rex said the Wilkins study is seriously flawed with regard to the detection rate, since 13,363 (73 percent) of 18,292 colonoscopies are derived from a single study, which was not reported in a peer reviewed journal. According to Dr. Rex, the colonoscopies from the study should have been excluded because the center employs a gastroenterologist and colorectal surgeon, one of whom is on site full-time to rescue procedures when primary care physicians fail to reach the cecum. Moreover, this center has claimed that primary care physicians have equal success rates in their initial procedures compared to those performed after they are fully trained. This could only be achieved with assistance from the specialist. Since this situation is seldom if ever seen elsewhere in clinical practice, the procedures in this report should have been excluded from the study by Wilkins et al., according to Dr. Rex.

For more information: www.acg.gi.org


Related Content

News | ACR

February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...

Time February 06, 2024
arrow
News | Colonoscopy Systems

A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.

Time August 26, 2019
arrow
News | Colonoscopy Systems

A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.

Time August 06, 2019
arrow
News | Colonoscopy Systems

Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.

Time April 15, 2019
arrow
News | Colonoscopy Systems

https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.

Time September 27, 2018
arrow
News | Colonoscopy Systems

Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an ingestible, capsule-based device for preparation-free colorectal cancer (CRC) screening. The company said data from the multicenter clinical investigation showed promising results for detecting patients with polyps in an un-prepped colon.

Time September 04, 2018
arrow
News | Colonoscopy Systems

An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.

Time May 30, 2018
arrow
News | Colonoscopy Systems

February 8, 2018 – The U.S. Food and Drug Administration (FDA) announced on February 7, 2018, that Pentax Medical’s ...

Time February 08, 2018
arrow
News | Colonoscopy Systems

August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper ...

Time August 31, 2017
arrow
News | Colonoscopy Systems

People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.

Time July 12, 2017
arrow
Subscribe Now